First Time Loading...
A

Acticor Biotech SA
PAR:ALACT

Watchlist Manager
Acticor Biotech SA
PAR:ALACT
Watchlist
Price: 0.72 EUR -7.69% Market Closed
Updated: Jun 1, 2024

Balance Sheet

Balance Sheet Decomposition
Acticor Biotech SA

Current Assets 13m
Cash & Short-Term Investments 8m
Receivables 4.4m
Other Current Assets 656k
Non-Current Assets 1.3m
Long-Term Investments 436k
PP&E 28k
Intangibles 713k
Other Non-Current Assets 86k
Current Liabilities 8.6m
Accounts Payable 5.3m
Short-Term Debt 1.9m
Other Current Liabilities 1.4m
Non-Current Liabilities 5.3m
Long-Term Debt 4.3m
Other Non-Current Liabilities 986k

Balance Sheet
Acticor Biotech SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
1
3
2
3
2
1
13
8
11
7
Cash
1
3
2
3
2
1
13
8
11
7
Short-Term Investments
4
6
2
0
0
0
0
0
0
0
Total Receivables
10
7
9
7
4
2
1
2
4
5
Accounts Receivables
8
5
6
6
3
1
1
1
1
1
Other Receivables
2
2
3
1
1
1
1
1
4
4
Inventory
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
1
1
0
0
1
1
0
Total Current Assets
16
17
13
12
7
4
14
10
17
12
PP&E Net
0
0
0
0
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
Intangible Assets
11
9
11
8
6
3
1
1
1
1
Goodwill
6
5
5
9
2
1
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
6
5
5
9
2
1
0
0
0
0
Total Assets
33
N/A
31
-5%
30
-4%
29
-5%
16
-45%
9
-45%
15
+80%
11
-28%
18
+62%
13
-28%
Liabilities
Accounts Payable
6
6
6
6
5
4
2
3
3
5
Accrued Liabilities
2
2
2
2
1
1
0
0
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
1
1
1
0
0
0
0
1
1
Other Current Liabilities
4
0
0
0
0
0
3
3
1
1
Total Current Liabilities
12
9
9
9
6
5
5
6
4
7
Long-Term Debt
1
4
4
3
3
3
1
2
2
7
Minority Interest
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
1
1
1
Total Liabilities
13
N/A
13
-4%
13
+0%
12
-8%
9
-21%
8
-14%
6
-21%
9
+46%
7
-26%
15
+121%
Equity
Common Stock
1
1
1
1
1
1
0
0
1
1
Retained Earnings
6
5
4
3
7
13
19
10
13
26
Additional Paid In Capital
13
13
13
13
13
13
27
12
23
23
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
19
N/A
18
-5%
17
-7%
17
-3%
6
-62%
0
-93%
9
+1 826%
2
-81%
11
+542%
2
N/A
Total Liabilities & Equity
33
N/A
31
-5%
30
-4%
29
-5%
16
-45%
9
-45%
15
+80%
11
-28%
18
+62%
13
-28%
Shares Outstanding
Common Shares Outstanding
3
3
3
3
3
3
11
11
11
11

See Also

Discover More